Safety of DOACs in patients with Child-Pugh Class C cirrhosis and atrial fibrillation.
Mark AyoubCarol FarisJulton Tomanguillo ChumbeEbubekir DaglilarNadeem AnwarVishnu NaravadiPublished in: JGH open : an open access journal of gastroenterology and hepatology (2024)
Anticoagulation is safe in patients with CPC with AF and may provide a mortality benefit. DOACs are a safer alternative to warfarin.